# A Phase II Trial Evaluating Irinotecan Plus 5FU/LV in Patients With Relapsed/Refractory Upper GI Tumours

> **NCT00220064** · PHASE2 · COMPLETED · sponsor: **Royal Marsden NHS Foundation Trust** · enrollment: 65 (actual)

## Conditions studied

- Upper Gastrointestinal Tumours

## Interventions

- **DRUG:** Irinotecan, 5-Fluorouracil, Leucovorin

## Key facts

- **NCT ID:** NCT00220064
- **Lead sponsor:** Royal Marsden NHS Foundation Trust
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-07
- **Primary completion:** —
- **Final completion:** 2005-11
- **Target enrollment:** 65 (ACTUAL)
- **Last updated:** 2013-05-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00220064

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00220064, "A Phase II Trial Evaluating Irinotecan Plus 5FU/LV in Patients With Relapsed/Refractory Upper GI Tumours". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00220064. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*